Evidence map›Paper›PMID 39863594›Full record

ArticleNature communications2025

Diversity-oriented synthesis of stereodefined tetrasubstituted alkenes via a modular alkyne gem-addition strategy.

Xuan Di, Sitian Zhou, Yali Qin, Wenjun Li, Yue Zhang, Jie Zhang, Xu Shen, Jie Han, Jin Xie, Hongming Jin

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xuan Di *School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Sitian Zhou *State Key Laboratory of Coordination Chemistry, Jiangsu Key Laboratory of Advanced Organic Materials, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, China.
Yali Qin *School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Wenjun Li *Jiangsu Key Laboratory of Drug Target Research and Drug Discovery of Neurodegenerative Disease, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Yue ZhangJiangsu Key Laboratory of Drug Target Research and Drug Discovery of Neurodegenerative Disease, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Jie ZhangSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Xu ShenJiangsu Key Laboratory of Drug Target Research and Drug Discovery of Neurodegenerative Disease, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Jie HanState Key Laboratory of Coordination Chemistry, Jiangsu Key Laboratory of Advanced Organic Materials, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, China. jie.han@nju.edu.cn.ORCID http://orcid.org/0009-0006-1076-1454
Jin XieState Key Laboratory of Coordination Chemistry, Jiangsu Key Laboratory of Advanced Organic Materials, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, China. xie@nju.edu.cn.ORCID http://orcid.org/0000-0003-2600-6139
Hongming JinSchool of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China. hmjin@njucm.edu.cn.ORCID http://orcid.org/0000-0002-5509-5436

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stereocontrolled construction of tetrasubstituted olefins has been an attractive issue yet remains challenging for synthetic chemists. In this manuscript, alkynyl selenides, when treated with ArBCl

Identifiers

PMID39863594
PMCPMC11763084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.